Cargando…

Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?

INTRODUCTION: Lung cancer is one of the most lethal malignancies; however, no serum marker has been routinely recommended until now. METHODS: This is a prospective case control study including two groups of patients: Group I—patients with advanced lung cancer and Group II—patients with benign lung d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastawisy, Ahmed El, azzouny, Mahmoud El, Mohammed, Gamal, allah, Ahmad Awad, Behiry, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907401/ https://www.ncbi.nlm.nih.gov/pubmed/24567753 http://dx.doi.org/10.3332/ecancer.2014.394

Ejemplares similares

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Clinical Usefulness of CYFRA Assay in Diagnosing Lung Cancer: Measurement of Serum Cytokeratin Fragment
por: Sugama, Yasuo, et al.
Publicado: (1994)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022)

Pathologic Correlation of Serum Carcinoembryonic Antigen and Cytokeratin 19 Fragment in Resected Nonsmall Cell Lung Cancer
por: Lee, Seokkee, et al.
Publicado: (2013)

Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia
por: Intke, Carina, et al.
Publicado: (2021)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients
por: Kong, Yanan, et al.
Publicado: (2013)

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015)

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
por: Nakata, B, et al.
Publicado: (2004)

Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer
por: Gao, Jia, et al.
Publicado: (2014)

Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
por: Giovanella, L., et al.
Publicado: (2017)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients
por: El-Zefzafy, Wafaa, et al.
Publicado: (2015)

Association of NKX2‐5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children
por: Behiry, Eman G., et al.
Publicado: (2019)

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2013)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
por: Eguchi, Akiko, et al.
Publicado: (2022)

Reply: Have we done the best that we could have done?
por: Arora, Rakesh C., et al.
Publicado: (2020)

El dolo eventual
por: Feijóo Sánchez, Bernardo
Publicado: (2002)

Principles of eventual consistency
por: Burckhardt, Sebastian
Publicado: (2014)

Mean platelet volume and serum uric acid in neonatal sepsis: A case-control study
por: Shalaby, Mohsen M., et al.
Publicado: (2017)

Serum and urine periostin and cytokeratin-18 in children with congenital obstructive nephropathy
por: Turczyn, Agnieszka, et al.
Publicado: (2022)

Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer
por: Sharma, Sushil Kumar, et al.
Publicado: (2015)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
por: Omar, Mahmoud, et al.
Publicado: (2015)

Serum Cytokeratin 18 as a Potential Early Marker for Chemotherapy Response in Breast Cancer Patients: A Prospective Study
por: Hendawy, Shimaa R, et al.
Publicado: (2023)

New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite
por: Alarfaj, Nawal Ahmed, et al.
Publicado: (2020)

Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients
por: Ulukaya, Engin, et al.
Publicado: (2011)

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
por: Völkel, Cosima, et al.
Publicado: (2021)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2018)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
por: Nisman, B, et al.
Publicado: (2008)

Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome
por: Oweira, Hani, et al.
Publicado: (2018)

Powering the future: how we will (eventually) solve the energy crisis and fuel the civilization of tomorrow
por: Laughlin, Robert B
Publicado: (2011)

Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
por: Carpes, Larissa Salomoni, et al.
Publicado: (2021)

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer
por: PANG, LI, et al.
Publicado: (2013)

Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity
por: Goralska, Joanna, et al.
Publicado: (2023)

Clinical Values of Elevated Serum Cytokeratin-18 Levels in Hepatitis: A Meta-Analysis
por: Yang, Zhao Hui, et al.
Publicado: (2015)

Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer
por: Xu, Jie, et al.
Publicado: (2021)

Stem Cell Therapy: The Eventual Future
por: Saini, Rajiv, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3tm8iluvm4vq1ma7agd775jp3d